Section 1 - Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2017 - Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2017 | Zoe
Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2017
1Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2017
Start here
Get a plain-English read of 1
Turn the raw legal text into a practical explanation grounded in Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2017.
Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2017
The Repatriation Commission prepares the following instrument.
Dated 8 June 2017
The Seal of the
Repatriation Commission
was affixed to this instrument in the
presence of:
Simon Lewis
Craig Orme
Major General Mark Kelly
President
DSC AM CSC
AO DSC
Deputy President
Commissioner
Approved on 23 June 2017
Dan Tehan
Minister for Veterans’ Affairs
Contents
1 Name
2 Commencement
3 Authority
4 Schedule 1—Modifications of the Repatriation Pharmaceutical Benefits Scheme
5 Schedule 2—Repeals
Schedule 1—Modifications of the Repatriation Pharmaceutical Benefits Scheme
Repatriation Pharmaceutical Benefits Scheme
Schedule 2—Repeals
Repatriation Pharmaceutical Benefits Scheme (Australian Participants in British Nuclear Tests) 2006
1 Name
This instrument is the Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2017.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information
Column 1 Column 2 Column 3
Provisions Commencement Date/Details
The whole of this instrument 1 July 2017. 1 July 2017
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 18 of the Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) Act 2006.
4 Schedule 1—Modifications of the Repatriation Pharmaceutical Benefits Scheme
The Repatriation Pharmaceutical Benefits Scheme is modified as set out in Schedule 1 to this instrument for the purposes of the Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) Act 2006.
5 Schedule 2—Repeals
Each instrument that is specified in Schedule 2 to this instrument is repealed as set out in the applicable item in that Schedule, and any other item in that Schedule has effect according to its terms.
Schedule 1—Modifications of the Repatriation Pharmaceutical Benefits Scheme
Repatriation Pharmaceutical Benefits Scheme
1 Sections 1A to 2
Omit the sections, substitute:
1 Name
This instrument is the Scheme.
2 Authorisation of Scheme
The Scheme is authorised by section 18 of the Act.
2A Purpose of Scheme
The Scheme enables Community Pharmacists to supply Pharmaceutical benefits to Eligible Persons.
2B Transitional provision
If:
(a) a thing was started under the Repatriation Pharmaceutical Benefits Scheme (Australian Participants in British Nuclear Tests) 2006 (No. R45/2013) before 1 July 2017; and
(b) immediately before that day, the thing has not been finished;
then, the thing may be finished under this Scheme on or after that day as if it had been started under this Scheme.
2 Section 3 (definition of Act)
Omit the definition, substitute:
Act means the Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) Act 2006;
3 Section 3 (definition of accepted disability)
Omit the definition.
4 Section 3 (definition of Eligible Person)
Omit the definition, substitute:
Eligible Person means an eligible person within the meaning of the Act;
5 Section 3
Omit the following definitions:
(a) definition of income support payment”;
(b) definition of income support payment under the Social Security Act 1991;
(c) definition of MRCA supplement;
(d) definition of pension supplement;
(e) definition of pharmaceutical allowance;
(f) definition of pharmaceutical reimbursement.
6 Section 3 (definition of Repatriation Health Card ‑ For All Conditions)
Omit the definition, substitute:
Repatriation Health Card ‑ For All Conditions means an identification card, or written authorisation, provided to an Eligible Person in relation to treatment for all injuries or diseases;
7 Section 3
Omit the following definitions:
(a) definition of Repatriation Health Card ‑ For Specific Conditions;
(b) definition of Repatriation Pharmaceutical Benefits Card;
(c) definition of revoked scheme;
(d) definition of RPBS.
8 Section 3 (definition of Scheme)
Omit the definition, substitute:
Scheme means the Repatriation Pharmaceutical Benefits Scheme as modified by the Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2017;
9 Section 3
Omit the following definitions:
(a) definition of social security pension supplement;
(b) definition of SRCA disability.
10 Section 3 (definition of Treatment Principles)
Omit the definition, substitute:
Treatment Principles means the Treatment Principles as modified by the Australian Participants in British Nuclear Tests and British Commonwealth Occupation Force (Treatment) (Modifications of the Treatment Principles) Instrument 2013;
11 Section 3
Omit the following definitions:
(a) definition of veterans supplement;
(b) definition of war widow/war widower pension;
(c) definition of war‑caused or defence‑caused injuries or diseases.
12 Section 16 (note)
Omit “the RPBS” (wherever occurring), substitute “the Scheme”.
13 Subsection 16A(9)
Omit “the Act”, substitute “the National Health Act 1953”.